Ethambutol — Membership Pricing
Ethambutol is not confirmed for no-additional-cost pricing. Membership pricing may be available; confirm the price with the dispensing pharmacy.
Ethambutol Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Membership pricing may be available |
| Typical Retail | $135.00 |
Membership pricing may be available; confirm the price with the dispensing pharmacy.
About Ethambutol
Ethambutol is a prescription medication. Ask your doctor if Ethambutol is right for you.
How to Check Ethambutol Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
Ethambutol at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Infections
About Ethambutol
Ethambutol is a vital medication primarily used to treat tuberculosis (TB), a serious bacterial infection. As a core component of multi-drug regimens, it plays a crucial role in combating this global health challenge. At TheDrugClub, we understand the importance of affordable access to essential medications like ethambutol, helping our members manage their health expenses.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What Ethambutol is approved for (FDA label)
Ethambutol hydrochloride is indicated for the treatment of pulmonary tuberculosis. It should not be used as the sole antituberculous drug, but should be used in conjunction with at least one other antituberculous drug. Selection of the companion drug should be based on clinical experience, considerations of comparative safety and appropriate in-vitro susceptibility studies. In patients who have not received previous antituberculous therapy, i.e., initial treatment, the most frequently used regimens have been the following: Ethambutol plus isoniazid Ethambutol plus isoniazid plus streptomycin. In patients who have received previous antituberculous therapy, mycobacterial resistance to other drugs used in initial therapy is frequent.
Source: Read the full FDA label on DailyMed. Label effective date: July 31, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Ethambutol (FDA label)
Ethambutol hydrochloride may produce decreases in visual acuity, including irreversible blindness, which appear to be due to optic neuritis. Optic neuropathy including optic neuritis or retrobulbar neuritis occurring in association with ethambutol therapy may be characterized by one or more of the following events: decreased visual acuity, scotoma, color blindness, and/or visual defect. These events have also been reported in the absence of a diagnosis of optic or retrobulbar neuritis. Patients should be advised to report promptly to their physician any change of visual acuity. The change in visual acuity may be unilateral or bilateral and hence each eye must be tested separately and both eyes tested together.
Source: FDA prescribing information (DailyMed). Set ID: c12b3482-55f0-4324-bdcd-b129ca2dae73. SPL document ID: 57e91f1f-73fe-8bd9-e063-6294a90a5f51. Label effective date: July 31, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Ethambutol (FDA label)
Ethambutol hydrochloride is contraindicated in patients who are known to be hypersensitive to this drug. It is also contraindicated in patients with known optic neuritis unless clinical judgement determines that it may be used. Ethambutol hydrochloride is contraindicated in patients who are unable to appreciate and report visual side effects or changes in vision (e.g., young children, unconscious patients).
Source: FDA prescribing information (DailyMed). Set ID: c12b3482-55f0-4324-bdcd-b129ca2dae73. SPL document ID: 57e91f1f-73fe-8bd9-e063-6294a90a5f51. Label effective date: July 31, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Drug interactions for Ethambutol (FDA label)
The results of a study of coadministration of ethambutol hydrochloride (50mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products. It is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing antacids for at least 4 hours following ethambutol administration.
Source: FDA prescribing information (DailyMed). Set ID: c12b3482-55f0-4324-bdcd-b129ca2dae73. SPL document ID: 57e91f1f-73fe-8bd9-e063-6294a90a5f51. Label effective date: July 31, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.